Comparison
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868 vs 46 Xx Gonadal Dysgenesis C0685837
Clinical comparison between 46 XY Disorder OF Sex Development Due TO A Cholesterol Synthesis Defect and 46 XX Gonadal Dysgenesis for differential diagnosis and treatment planning.
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
A genetic condition impairing cholesterol synthesis, affecting sex hormone production. Typically part of Smith-Lemli-Opitz syndrome. Treatment focuses on cholesterol supplementation and hormone support.
46 Xx Gonadal Dysgenesis C0685837
A condition affecting ovarian development in individuals with two X chromosomes. May impact puberty and fertility. Treatment typically includes hormone replacement and supportive care.
6 comparison axes
Onset
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
0-0
46 Xx Gonadal Dysgenesis C0685837
12-16
Onset patterns differ
Severity
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
severe
46 Xx Gonadal Dysgenesis C0685837
moderate
Different severity levels
Chronic
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
Chronic
46 Xx Gonadal Dysgenesis C0685837
Chronic
Differing course
Communicable
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
No
46 Xx Gonadal Dysgenesis C0685837
No
Different transmission
Body System
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
reproductive
46 Xx Gonadal Dysgenesis C0685837
reproductive
Same/different system
Category
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
metabolic
46 Xx Gonadal Dysgenesis C0685837
genetic
Different category
Bottom line
46-xy-disorder-of-sex-development-due-to-a-cholesterol-synthesis-defect-C5679868 and 46-xx-gonadal-dysgenesis-C0685837 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868 | 46 Xx Gonadal Dysgenesis C0685837 | Discriminating power |
|---|---|---|---|
| Genital appearance | Atypical genital development may be present at birth in a 46,XY infant. | External genitalia are typically female; findings may not be obvious at birth. | High |
| Pubertal development | Sex-hormone deficiency may occur, but multisystem features often dominate earlier. | Absent or incomplete puberty and primary amenorrhea are typical concerns. | High |
| Associated features | Growth, developmental, and congenital anomalies may accompany the metabolic defect. | Features are mainly gonadal and reproductive unless another syndrome is identified. | Moderate |
When to favor each condition
Choose 46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868 when
Newborn with atypical genitalia and suspected metabolic or syndromic disease
Congenital onset and cholesterol-synthesis impairment fit the left condition better.
Moderate
46,XY karyotype with impaired androgen or sex-hormone production
The chromosomal pattern matches the left disorder rather than 46,XX gonadal dysgenesis.
High
Features suggestive of Smith-Lemli-Opitz syndrome
The supplied description links this DSD to that cholesterol-synthesis disorder.
Moderate
Choose 46 Xx Gonadal Dysgenesis C0685837 when
Adolescent with absent puberty or primary amenorrhea
The supplied onset is around ages 12-16, unlike congenital presentation.
Moderate
46,XX karyotype with impaired ovarian development
Two X chromosomes and ovarian dysgenesis define the right condition.
High
Mainly reproductive concerns without a known cholesterol defect
The right condition is genetic and generally less systemically severe in the source data.
Moderate
How key tests differ
| Test | 46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868 | 46 Xx Gonadal Dysgenesis C0685837 | Interpretation |
|---|---|---|---|
| Karyotype | 46,XY expected by definition. | 46,XX expected by definition. | Chromosomal sex is a primary discriminator; confirm in an accredited laboratory. |
| Sterol or cholesterol pathway testing | Abnormal cholesterol synthesis may be found; exact cutoffs are not supplied. | No cholesterol-synthesis defect is expected from the source description. | An abnormal sterol result supports, but does not alone diagnose, the left condition. |
| Gonadal and hormone evaluation | Sex-hormone production may be impaired; pattern depends on clinical context. | Ovarian function is reduced, often with absent puberty or amenorrhea. | Results require specialist interpretation and do not replace genetic assessment. |
Prognosis comparison
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
- Outcome
- Chronic and potentially severe, with outcome depending on syndrome severity and associated anomalies.
- Factors
- Extent of cholesterol-synthesis impairment, congenital anomalies, and developmental involvement.
46 Xx Gonadal Dysgenesis C0685837
- Outcome
- Chronic but generally moderate reproductive condition; puberty and fertility are key issues.
- Factors
- Degree of ovarian dysgenesis, hormone replacement, and associated diagnoses.
Time frame: Left often recognized at birth; right often recognized around expected puberty.
Exact mortality and long-term outcomes are not established by the supplied data.
Complications comparison
| Complication | Presentation |
|---|---|
| Fertility limitation | Sex-hormone and developmental abnormalities may affect reproductive potential. Ovarian dysgenesis commonly causes infertility or severely reduced fertility. Fertility outcomes vary and should be discussed individually. |
| Hormone deficiency | May require hormone support alongside metabolic care. Often managed with hormone replacement and supportive care. No dose or regimen is established by these source data. |
| Broader health effects | Severe multisystem effects may occur, especially in Smith-Lemli-Opitz syndrome. Effects are mainly pubertal, reproductive, and psychosocial in the supplied description. Severity labels differ, but individual prognosis is not determined here. |
Patient education highlights
- HighDistinct conditions
One is a 46,XY cholesterol-synthesis disorder; the other is 46,XX impaired ovarian development.
- HighSpecialist care
Endocrine, genetics, and reproductive specialists should interpret tests and guide care.
- MediumSupportive treatment
Care may include hormone support; cholesterol supplementation is described for the left condition.